Comment on the article: In vivo Pharmacokinetics/Pharmacodynamics Profiles for Appropriate Doses of Cefditoren pivoxil against S. pneumoniae in Murine Lung-Infection Model
- PMID: 38997597
- DOI: 10.1007/s11095-024-03729-8
Comment on the article: In vivo Pharmacokinetics/Pharmacodynamics Profiles for Appropriate Doses of Cefditoren pivoxil against S. pneumoniae in Murine Lung-Infection Model
Erratum in
-
Correction: Comment on the article: In vivo Pharmacokinetics/Pharmacodynamics Profiles for Appropriate Doses of Cefditoren pivoxil against S. pneumoniae in Murine Lung-Infection Model.Pharm Res. 2024 Aug;41(8):1755. doi: 10.1007/s11095-024-03753-8. Pharm Res. 2024. PMID: 39107516 No abstract available.
Keywords: streptococcus pneumoniae; PK/PD; cefditoren; population analysis.
References
-
- Torrico M, Aguilar L, González N, Giménez MJ, Echeverría O, Cafini F, et al. Influence of TEM-1 β-lactamase on the pharmacodynamic activity of simulated total versus free-drug serum concentrations of cefditoren (400 milligrams) versus amoxicillin-clavulanic acid (2,000/125 milligrams) against Haemophilus influenzae strains exhibit. Antimicrob Agents Chemother. 2007;51(10):3699–706. - DOI - PubMed - PMC
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
